A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes ...

The FDA has received six adverse event reports connected to this specific lot of Ozempic (all submitted by Novo Nordisk), but ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

The US Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout for counterfeit Ozempic (semaglutide) and to refrain from using the imitation ...

The agency and Novo Nordisk, which makes Ozempic, said Monday that they had learned about "several hundred units" of the drug ...

The Food and Drug Administration issued an alert on Monday concerning counterfeit Ozempic that could be in the U.S. drug ...

Danish drugmaker Novo Nordisk said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Co. (PG ...

While Ozempic is designed specifically for diabetes treatment, Wegovy addresses the unique needs of patients living with obesity. BT: How does Novo Nordisk view competition in the obesity ...

As a pioneer in diabetes care, Novo Nordisk NVO claims 34% of the USD 80 ... negotiation for their key drug semaglutide, Wegovy/Ozempic/Rybelsus, in 2027 - it’s not clear how far the Trump ...

So I literally have been working on this for 40 years. When did Novo Nordisk (manufacturer of Ozempic and Wegovy) become involved? I think the big companies, Novo Nordisk and Eli Lilly ...